Can you take ondansetron while pregnant?

Drugs.com

Official answer

by Drugs.com

Although ondansetron is not specifically approved by the FDA to treat nausea and vomiting during pregnancy (NVP), its use is common, and approximately 25% of pregnant women are prescribed ondansetron to treat NVP. Overall, studies show the use of ondansetron appears to be associated with an additional 3 instances of oral cleft defects (such as cleft lip or cleft palate) for every 10,000 women exposed to ondansetron during their first trimester. There may also be a very slight increased risk of a type of heart defect called a ventricular septal defect, but no apparent increased risk of other birth defects, miscarriage, or fetal death.

Within these studies, it is impossible to rule out confounding variables – such as metabolic changes and severe nutritional deficiencies that are common in pregnant women with severe NVP. Any of these can also increase the risk of oral cleft defects. In addition, prolonged severe NVP is associated with increased anxiety and depression which has led to the termination of pregnancy in some cases. Physicians must weigh up all the risks and benefits for each pregnancy before deciding to prescribe ondansetron.

The main studies that investigated the use of ondansetron during pregnancy have included:

  • Dormuth et al, 2021: A meta-analysis of 456 963 pregnancies in 3 countries reported that the use of ondansetron was not associated with an increased risk of miscarriage, fetal death, or major birth deformities compared with using other antiemetics (such as metoclopramide, promethazine, doxylamine) during pregnancy.
  • Andrade 2020: A review of previously published cohort and case-control studies suggests early exposure to ondansetron does increase the risk of orofacial defects (absolute increased risk 0.03%) and ventricular septal defects (absolute increased risk 0.3%).
  • Huybrechts et al, 2018: A retrospective Medicaid data analyses of 1,816,414 pregnancies from 2000 to 2013; 88,467 (4.9 percent) of which were associated with ondansetron exposure during the first trimester. Oral cleft defects occurred in 14 per 10,000 exposed infants compared to 11.1 per 10,000 unexposed infants (ARR 1.24, 95% CI: 1.03–1.48)
  • Zambelli-Weiner et al, 2018: A retrospective analysis of medical claims data from 864,083 mother-child pairs registered from 2000 to 2014 of whom 5,557 mother-child pairs were administered ondansetron in the first trimester. There was a non-significant increase in orofacial cleft defects (OR: 1.30, 95% CI: 0.76–2.28) and an increased risk of cardiac defects (OR: 1.52, 95% CI: 1.35-1.70).

    • Repeated fetal scanning during the second trimester can help with the early detection of malformations if needed.

    Related medical questions

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords